Cargando…
Induction Chemotherapy Followed by Primary Tumor Resection Did Not Bring Survival Benefits in Colon Cancer Patients With Asymptomatic Primary Lesion and Synchronous Unresectable Metastases
BACKGROUND: It is still controversial whether primary tumor resection (PTR) improves survival in colorectal cancer (CRC) patients with unresectable metastases. METHODS: Colon cancer patients were enrolled and randomly allocated to with or without PTR after induction chemotherapy with XELOX or mFOLFO...
Autores principales: | Huang, Mingzhu, Yang, Ya’nan, Li, Qingguo, Wang, Chenchen, Liang, Lei, Zhu, Xiaodong, Zhang, Wen, Chen, Zhiyu, Huang, Dan, Li, Wenhua, Zhang, Xiaowei, Zhao, Xiaoying, Qiu, Lixin, Geng, Qirong, Yu, Nuoya, Du, Wenfang, Sun, Sijie, Sheng, Xuedan, Li, Xinxiang, Guo, Weijian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841852/ https://www.ncbi.nlm.nih.gov/pubmed/35174078 http://dx.doi.org/10.3389/fonc.2022.747124 |
Ejemplares similares
-
Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial
por: Zhao, Xiaoying, et al.
Publicado: (2023) -
A prospective phase II study of raltitrexed combined with S‐1 as salvage treatment for patients with refractory metastatic colorectal cancer
por: Huang, Mingzhu, et al.
Publicado: (2021) -
Apatinib for patients with metastatic biliary tract carcinoma
refractory to standard chemotherapy: results from an investigator-initiated,
open-label, single-arm, exploratory phase II study
por: Wang, Chenchen, et al.
Publicado: (2021) -
FOLFIRI (folinic acid, fluorouracil, and irinotecan) increases not efficacy but toxicity compared with single-agent irinotecan as a second-line treatment in metastatic colorectal cancer patients: a randomized clinical trial
por: Zhang, Xiaowei, et al.
Publicado: (2022) -
Maintenance treatment of Uracil and Tegafur (UFT) in responders following first-line fluorouracil-based chemotherapy in metastatic gastric cancer: a randomized phase II study
por: Li, Wenhua, et al.
Publicado: (2016)